Lennernäs H - Search Results

1

The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance.

Selen A, Dickinson PA, Müllertz A, Crison JR, Mistry HB, Cruañes MT, Martinez MN, Lennernäs H, Wigal TL, Swinney DC, Polli JE, Serajuddin ATM, Cook JA, Dressman JB. Selen A, et al. Among authors: lennernas h. J Pharm Sci. 2014 Nov;103(11):3377-3397. doi: 10.1002/jps.24162. Epub 2014 Sep 24. J Pharm Sci. 2014. PMID: 25256402 Review.

2

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Amidon GL, Lennernäs H, Shah VP, Crison JR. Amidon GL, et al. Among authors: lennernas h. Pharm Res. 1995 Mar;12(3):413-20. doi: 10.1023/a:1016212804288. Pharm Res. 1995. PMID: 7617530 Free article.

3

Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation?

Lennernäs H. Lennernäs H. Pharm Res. 1995 Nov;12(11):1573-82. doi: 10.1023/a:1016220428705. Pharm Res. 1995. PMID: 8592653 Review.

4

Permeability and clearance views of drug absorption: a commentary.

Lennernäs H, Crison JR, Amidon GL. Lennernäs H, et al. J Pharmacokinet Biopharm. 1995 Jun;23(3):333-43. doi: 10.1007/BF02354289. J Pharmacokinet Biopharm. 1995. PMID: 8834200 Free article. No abstract available.

5

Dissolution of hydrocortisone in human and simulated intestinal fluids.

Pedersen BL, Brøndsted H, Lennernäs H, Christensen FN, Müllertz A, Kristensen HG. Pedersen BL, et al. Among authors: lennernas h. Pharm Res. 2000 Feb;17(2):183-9. doi: 10.1023/a:1007517414200. Pharm Res. 2000. PMID: 10751033

6

Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs.

Tronde A, Nordén B, Marchner H, Wendel AK, Lennernäs H, Bengtsson UH. Tronde A, et al. Among authors: lennernas h. J Pharm Sci. 2003 Jun;92(6):1216-33. doi: 10.1002/jps.10386. J Pharm Sci. 2003. PMID: 12761811

7

In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance.

Bredenberg S, Duberg M, Lennernäs B, Lennernäs H, Pettersson A, Westerberg M, Nyström C. Bredenberg S, et al. Among authors: lennernas h, lennernas b. Eur J Pharm Sci. 2003 Nov;20(3):327-34. doi: 10.1016/j.ejps.2003.07.002. Eur J Pharm Sci. 2003. PMID: 14592698

8

Pharmacokinetics of gefitinib in humans: the influence of gastrointestinal factors.

Bergman E, Forsell P, Persson EM, Knutson L, Dickinson P, Smith R, Swaisland H, Farmer MR, Cantarini MV, Lennernäs H. Bergman E, et al. Among authors: lennernas h. Int J Pharm. 2007 Aug 16;341(1-2):134-42. doi: 10.1016/j.ijpharm.2007.04.002. Epub 2007 Apr 6. Int J Pharm. 2007. PMID: 17482782 Clinical Trial.

9

The use of BDDCS in classifying the permeability of marketed drugs.

Benet LZ, Amidon GL, Barends DM, Lennernäs H, Polli JE, Shah VP, Stavchansky SA, Yu LX. Benet LZ, et al. Among authors: lennernas h. Pharm Res. 2008 Mar;25(3):483-8. doi: 10.1007/s11095-007-9523-x. Epub 2008 Jan 31. Pharm Res. 2008. PMID: 18236138 Free PMC article.

10

Different effects of ketoconazole on the stereoselective first-pass metabolism of R/S-verapamil in the intestine and the liver: important for the mechanistic understanding of first-pass drug-drug interactions.

Thörn HA, Hedeland M, Bondesson U, Knutson L, Yasin M, Dickinson P, Lennernäs H. Thörn HA, et al. Among authors: lennernas h. Drug Metab Dispos. 2009 Nov;37(11):2186-96. doi: 10.1124/dmd.109.028027. Epub 2009 Aug 17. Drug Metab Dispos. 2009. PMID: 19687151

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

252 results

Search Page